- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT00928460
Efficacy of Preoperative Electrocardiography
The Efficacy of Routine Preoperative Electrocardiography in Patients Undergoing Non-cardiac Surgery
Обзор исследования
Статус
Вмешательство/лечение
Подробное описание
Objective:
A routine ECG is performed as part of the standard diagnostic workup before non-cardiac surgery. However, the added value of this test beyond patient history and physical examination is questionable. The proposed study therefore aims to determine whether preoperative assessment without ECG is more cost-effective.
Study design:
Prospective stepped wedge design multicenter trial including 40,000 patients.
Study population:
All patients aged over 60 years, or younger patients with cardiovascular risk factors, scheduled for non-cardiac surgery with an expected postoperative hospital stay of at least 2 days.
Intervention:
A new preoperative assessment strategy without routine ECG. Initially, all patients in the participating centers are assessed following the regular strategy (with routine ECG). The new strategy (without routine ECG) is rolled out to the participating hospitals sequentially. At the end of the trial all participating centers will use the new preoperative strategy.
Outcome measures:
The primary outcome measure is cardiac death or perioperative myocardial infarction. The latter will be verified by Troponin values at postoperative day 1 and 2. If the Troponin levels are elevated the presence of myocardial infarction will be evaluated by a consulting cardiologist. Secondary outcomes are other major cardiovascular complications, death from other causes within 2 days of surgery, and long term quality of life. To determine cost-effectiveness of the strategy without ECG all pre- and postoperative referrals and interventions are taken into account.
Sample size calculation:
We expect no increase in the primary outcome in the intervention group. To rule out an 0.5% increase (from 3% to 3.5%) in the intervention group, the inclusion of 36,504 patients is required (level of confidence: 0.95; power: 0.80). To compensate for expected 10% loss-to-follow up, 40,000 patients will be randomized.
Economic evaluation:
A cost-effectiveness analysis will be conducted when the increase in primary outcome is between 0.0 and 0.5%. If the intervention results in a lower prevalence of the primary outcome, no cost-effectiveness analysis is performed as the health and cost outcomes point in the same, advantageous, direction. An increase of more than 0.5% is not considered acceptable from a clinical point of view.
Тип исследования
Контакты и местонахождение
Места учебы
-
-
-
Utrecht, Нидерланды, 3508 GA
- University Medical Center Utrecht
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Метод выборки
Исследуемая популяция
Описание
Inclusion Criteria:
- All patients aged 60 years or older scheduled for noncardiac surgery with an expected hospital length of stay of at least 2 days
- Patients aged under 60 years but with risk factors for cardiovascular disease scheduled for noncardiac surgery with an expected hospital length of stay of at least 2 days
Exclusion Criteria:
- Patients refusing informed consent for obtaining blood samples (troponin measurement) at the first two days after surgery
- Patients refusing participation in long-term clinical and Quality of Life measurements
Учебный план
Как устроено исследование?
Детали дизайна
Когорты и вмешательства
Группа / когорта |
Вмешательство/лечение |
---|---|
Regular preanesthesia evaluation
Patients are evaluated by the anesthesiologist according to current protocol, including routine preoperative ECG.
|
|
New preanesthesia evaluation
Patients are evaluated by the anesthesiologist according to a new protocol, in which a routine preoperative ECG is no longer provided.
|
A new preanesthesia evaluation strategy without routine ECG.
Initially, all patients in the participating centers are assessed following the regular strategy (with routine ECG).
The new strategy (without routine ECG) is rolled out to the participating hospitals sequentially.
At the end of the trial all participating centers will use the new preoperative strategy.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Временное ограничение |
---|---|
Cardiac death or perioperative myocardial infarction
Временное ограничение: 2 days postoperatively
|
2 days postoperatively
|
Вторичные показатели результатов
Мера результата |
Временное ограничение |
---|---|
Other major cardiovascular complications
Временное ограничение: 2 days postoperatively
|
2 days postoperatively
|
Death from other causes
Временное ограничение: 2 days postoperatively
|
2 days postoperatively
|
Long term quality of life
Временное ограничение: One year
|
One year
|
Соавторы и исследователи
Спонсор
Следователи
- Учебный стул: Cor J Kalkman, MD PhD, UMC Utrecht
- Главный следователь: Wilton A van Klei, MD PhD, UMC Utrecht
- Главный следователь: Jurgen C de Graaff, MD PhD, UMC Utrecht
Публикации и полезные ссылки
Даты записи исследования
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Оценивать)
Обновления учебных записей
Последнее опубликованное обновление (Оценивать)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- ECGtrial
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .